Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel Combined With Local Therapy in ES-SCLC
NCT07547332Phase 2Not yet recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Apr 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of paclitaxel in small cell lung cancer (SCLC), sponsored by Shanghai Pulmonary Hospital. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
paclitaxel
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT07547332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07547332.